Fabagal®
International nonproprietary name
Agalsidase beta
Description
A drug for therapy of the orphan Fabry disease.
Application
For long-term enzyme replacement therapy of patients with confirmed diagnosis of Fabry disease (a rare genetically determined disease, causing kidney problems, neuropathic limb pain, congestive heart failure and stroke).